Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review

被引:9
|
作者
Wright, Stuart J. [1 ]
Newman, William G. [2 ,3 ]
Payne, Katherine [1 ]
机构
[1] Univ Manchester, Manchester Ctr Hlth Econ, Div Populat Hlth Hlth Serv Res & Primary Care, Oxford Rd, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Div Evolut & Genom Sci, Manchester Ctr Genom Med, Manchester, Lancs, England
[3] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, North West Genom Lab Hub, Manchester, Lancs, England
基金
英国惠康基金; 芬兰科学院;
关键词
COST-EFFECTIVENESS ANALYSIS; STAGE BREAST-CANCER; HEALTH-CARE; PERSONALIZED MEDICINE; TRASTUZUMAB THERAPY; HORMONE-RECEPTOR; BARRIERS; WOMEN; ASSAY; IMPLEMENTATION;
D O I
10.1007/s40273-019-00801-9
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and Objective Precision (stratified or personalised) medicine is underpinned by the premise that it is feasible to identify known heterogeneity using a specific test or algorithm in patient populations and to use this information to guide patient care to improve health and well-being. This study aimed to understand if, and how, previous economic evaluations of precision medicine had taken account of the impact of capacity constraints. Methods A meta-review was conducted of published systematic reviews of economic evaluations of precision medicine (test-treat interventions) and individual studies included in these reviews. Due to the volume of studies identified, a sample of papers published from 2007 to 2015 was collated. A narrative analysis identified whether potential capacity constraints were discussed qualitatively in the studies and, if relevant, which quantitative methods were used to account for capacity constraints. Results A total of 45 systematic reviews of economic evaluations of precision medicine were identified, from which 222 studies focusing on test-treat interventions, published between 2007 and 2015, were extracted. Of these studies, 33 (15%) qualitatively discussed the potential impact of capacity constraints, including budget constraints; quality of tests and the testing process; ease of use of tests in clinical practice; and decision uncertainty. Quantitative methods (nine studies) to account for capacity constraints included static methods such as capturing inefficiencies in trials or models and sensitivity analysis around model parameters; and dynamic methods, which allow the impact of capacity constraints on cost effectiveness to change over time. Conclusions Understanding the cost effectiveness of precision medicine is necessary, but not sufficient, evidence for its successful implementation. There are currently few examples of evaluations that have quantified the impact of capacity constraints, which suggests an area of focus for future research.
引用
收藏
页码:1011 / 1027
页数:17
相关论文
共 50 条
  • [31] Genetic testing and economic evaluations: a systematic review of the literature
    D'Andrea, Elvira
    Marzuillo, Carolina
    Pelone, Ferruccio
    De Vito, Corrado
    Villari, Paolo
    [J]. EPIDEMIOLOGIA & PREVENZIONE, 2015, 39 (04): : 45 - 50
  • [32] Economic evaluations in shoulder pathologies: a systematic review of the literature
    Kuye, Ifedayo O.
    Jain, Nitin B.
    Warner, Lauren
    Herndon, James H.
    Warner, Jon J. P.
    [J]. JOURNAL OF SHOULDER AND ELBOW SURGERY, 2012, 21 (03) : 367 - 375
  • [33] Health Economic Evaluations of Cancer in Brazil: A Systematic Review
    Campolina, Alessandro G.
    Yuba, Tania Y.
    Decimoni, Tassia C.
    Leandro, Roseli
    Estevez Diz, Maria del Pilar
    Novaes, Hillegonda M. D.
    de Soarez, Patricia C.
    [J]. FRONTIERS IN PUBLIC HEALTH, 2018, 6
  • [34] Economic evaluations of musculoskeletal physiotherapy: protocol of a systematic review
    Baumbach, Linda
    Koenig, Hans-Helmut
    Kretzler, Benedikt
    Hajek, Andre
    [J]. BMJ OPEN, 2022, 12 (02):
  • [35] A systematic review of health economic evaluations of vaccines in Brazil
    Christovam Sartori, Ana Marli
    Rozman, Luciana Martins
    Decimoni, Tassia Cristina
    Leandro, Roseli
    Dutilh Novaes, Hillegonda Maria
    de Soarez, Patricia Coelho
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (06) : 1454 - 1465
  • [36] Community Distribution of Naloxone: A Systematic Review of Economic Evaluations
    Cherrier, Nelda
    Kearon, Joanne
    Tetreault, Robin
    Garasia, Sophiya
    Guindon, Emmanuel
    [J]. PHARMACOECONOMICS-OPEN, 2022, 6 (03) : 329 - 342
  • [37] A systematic review of economic evaluations of genetic testing technologies
    Ramsey, S
    Henrikson, N
    Carlson, J
    Veenstra, DL
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 375 - 375
  • [38] Perspectives in prospective comparative economic evaluations: a systematic review
    Guerre, Pascale
    Huot, Laure
    Colin, Cyrille
    Marrel, Adrien
    Rabier, Hugo
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (03) : 273 - 280
  • [39] Economic evaluations of psychosocial interventions in cancer: A systematic review
    Dieng, Mbathio
    Cust, Anne E.
    Kasparian, Nadine A.
    Mann, Graham J.
    Morton, Rachael L.
    [J]. PSYCHO-ONCOLOGY, 2016, 25 (SP. S3) : 104 - 104
  • [40] Systematic review of economic evaluations of varicella vaccination programmes
    Anderson, Robert
    Kim, Sungwook
    Roberts, Nia
    Petrou, Stavros
    [J]. PLOS ONE, 2023, 18 (03):